X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2335) 2335
Publication (418) 418
Book Review (29) 29
Book Chapter (21) 21
Conference Proceeding (6) 6
Dissertation (6) 6
Book / eBook (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (1665) 1665
humans (1544) 1544
index medicus (1454) 1454
mice (1213) 1213
cell biology (787) 787
proto-oncogene proteins c-myc - metabolism (680) 680
apoptosis (650) 650
oncology (631) 631
cancer (546) 546
proto-oncogene proteins c-myc - genetics (530) 530
signal transduction (519) 519
biochemistry & molecular biology (504) 504
c-myc (496) 496
expression (478) 478
cell proliferation (440) 440
male (440) 440
female (436) 436
cell line, tumor (406) 406
gene expression (405) 405
proteins (389) 389
mice, knockout (379) 379
research (378) 378
article (353) 353
genetic aspects (312) 312
gene expression regulation, neoplastic (307) 307
activation (279) 279
mutation (278) 278
phosphorylation (277) 277
mice, inbred c57bl (272) 272
proto-oncogene proteins - genetics (269) 269
cells, cultured (268) 268
proto-oncogene proteins - metabolism (265) 265
research article (263) 263
cell cycle (258) 258
proto-oncogene proteins c-akt - metabolism (256) 256
tumors (254) 254
multidisciplinary sciences (249) 249
physiological aspects (244) 244
gene-expression (232) 232
biology (230) 230
mice, transgenic (225) 225
cell line (218) 218
differentiation (215) 215
kinases (206) 206
medicine (200) 200
in-vivo (195) 195
analysis (194) 194
health aspects (192) 192
tumor suppressor protein p53 - metabolism (192) 192
gene expression regulation (189) 189
genetics & heredity (189) 189
apoptosis - drug effects (188) 188
gene (188) 188
cell differentiation (187) 187
cells (187) 187
stem cells (183) 183
rodents (182) 182
proliferation (177) 177
genes (176) 176
science (169) 169
transcription factors (165) 165
tumorigenesis (164) 164
immunology (163) 163
p53 (163) 163
growth (162) 162
rats (162) 162
tumor suppressor protein p53 - genetics (149) 149
transgenic mice (148) 148
development and progression (144) 144
proto-oncogene proteins c-bcl-2 - metabolism (143) 143
hematology (142) 142
protein (142) 142
transfection (142) 142
myc (141) 141
transcription factors - metabolism (141) 141
medicine, research & experimental (139) 139
genetics (138) 138
signal transduction - drug effects (138) 138
apoptosis - genetics (137) 137
cell growth (135) 135
cell transformation, neoplastic - genetics (135) 135
rna interference (135) 135
disease models, animal (133) 133
immunohistochemistry (132) 132
myc protein (132) 132
dna-binding proteins - metabolism (127) 127
down-regulation (125) 125
transcription (123) 123
transcription factors - genetics (122) 122
blotting, western (120) 120
reverse transcriptase polymerase chain reaction (120) 120
protein binding (119) 119
middle aged (117) 117
proto-oncogene proteins c-bcl-2 - genetics (117) 117
signal transduction - physiology (117) 117
cell proliferation - drug effects (116) 116
phenotype (115) 115
dna-binding proteins - genetics (114) 114
dna (113) 113
mouse (113) 113
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature, ISSN 0028-0836, 06/2016, Volume 534, Issue 7607, pp. 341 - 346
Chronic myeloid leukaemia (CML) arises after transformation of a haemopoietic stem cell (HSC) by the protein-tyrosine kinase BCR-ABL. Direct inhibition of... 
CD34(+) CELLS | INHIBITION | MICROARRAY | TYROSINE KINASE | MULTIDISCIPLINARY SCIENCES | IMATINIB | TUMOR | COMBINATION | CANCER | EXPRESSION | CHRONIC MYELOID-LEUKEMIA | Antigens, CD34 - metabolism | Tumor Suppressor Protein p53 - antagonists & inhibitors | Neoplastic Stem Cells - drug effects | Humans | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Transcriptome | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Acetamides - pharmacology | Male | Neoplasm Proteins - metabolism | Tumor Suppressor Protein p53 - genetics | DNA-Binding Proteins - metabolism | Imatinib Mesylate - therapeutic use | Acetamides - therapeutic use | Neoplastic Stem Cells - metabolism | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | Imidazolines - therapeutic use | Neoplastic Stem Cells - pathology | Female | Cell Death - drug effects | Hematopoietic Stem Cells - drug effects | Reproducibility of Results | Imatinib Mesylate - pharmacology | Tumor Suppressor Protein p53 - metabolism | Imidazolines - pharmacology | Hematopoietic Stem Cells - metabolism | Tumor Suppressor Protein p53 - deficiency | Proto-Oncogene Proteins c-myc - metabolism | Neoplastic Stem Cells - transplantation | Azepines - therapeutic use | Azepines - pharmacology | Animals | Signal Transduction - drug effects | Cell Differentiation - drug effects | Hematopoietic Stem Cells - cytology | Proto-Oncogene Proteins c-myc - deficiency | Proteomics | Proto-Oncogene Proteins c-myc - antagonists & inhibitors | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - metabolism | Mice | Proto-Oncogene Proteins c-myc - genetics | Fusion Proteins, bcr-abl - metabolism | Molecular targeted therapy | Cancer cells | Stem cells | Development and progression | Genetic aspects | Chronic myeloid leukemia | Tumor proteins | Properties | Health aspects | Methods | Proteins | Transcription factors | Leukemia | Cell cycle | Kinases | Cancer therapies | Apoptosis
Journal Article
Nature Immunology, ISSN 1529-2908, 11/2012, Volume 13, Issue 11, pp. 1092 - 1100
Journal Article
Genes and Development, ISSN 0890-9369, 05/2013, Volume 27, Issue 10, pp. 1101 - 1114
Tumorigenesis results from dysregulation of oncogenes and tumor suppressors that influence cellular proliferation, differentiation, apoptosis, and/or... 
Huwe1 | c-Myc | Mule | Ras | p21 | Miz1 | DNA-DAMAGE | KERATINOCYTE GROWTH | DEVELOPMENTAL BIOLOGY | CELL BIOLOGY | BASE EXCISION-REPAIR | HUWE1 UBIQUITIN LIGASE | NEGATIVE REGULATION | GENETICS & HEREDITY | ARF TUMOR-SUPPRESSOR | DIFFERENTIATION | MIZ-1 | HUMAN CANCER | Protein Inhibitors of Activated STAT - deficiency | Tetradecanoylphorbol Acetate - pharmacology | 9,10-Dimethyl-1,2-benzanthracene - pharmacology | Male | Protein Inhibitors of Activated STAT - metabolism | Cyclin-Dependent Kinase Inhibitor p15 - biosynthesis | Oncogene Protein p21(ras) - metabolism | Cyclin-Dependent Kinase Inhibitor p16 | Oncogene Protein p21(ras) - antagonists & inhibitors | Cyclin-Dependent Kinase Inhibitor p21 - genetics | Cell Transformation, Neoplastic - genetics | Cyclin-Dependent Kinase Inhibitor p15 - genetics | Nuclear Proteins - deficiency | Protein Inhibitors of Activated STAT - genetics | Cyclin-Dependent Kinase Inhibitor p21 - metabolism | Female | Nuclear Proteins - genetics | Protein Inhibitors of Activated STAT - antagonists & inhibitors | Skin Neoplasms - pathology | Cyclin-Dependent Kinase Inhibitor p21 - biosynthesis | Signal Transduction | Down-Regulation | Cells, Cultured | Ubiquitin-Protein Ligases - metabolism | Nuclear Proteins - metabolism | Skin Neoplasms - chemically induced | Proto-Oncogene Proteins c-myc - metabolism | Mice, Knockout | Skin Neoplasms - metabolism | Keratinocytes - pathology | Animals | Tumor Suppressor Protein p53 | Keratinocytes - drug effects | Keratinocytes - metabolism | Nuclear Proteins - antagonists & inhibitors | Proto-Oncogene Proteins c-myc - deficiency | Skin Neoplasms - genetics | Proto-Oncogene Proteins c-myc - antagonists & inhibitors | Ubiquitin-Protein Ligases - deficiency | Mice | Proto-Oncogene Proteins c-myc - genetics | Cyclin-Dependent Kinase Inhibitor p15 - metabolism | Genes, ras | Ubiquitin-Protein Ligases - genetics | Oncogene Protein p21(ras) - genetics | Carcinogenesis | Ras genes | Analysis | Research Paper
Journal Article
Nature, ISSN 0028-0836, 01/2016, Volume 529, Issue 7585, pp. 216 - 220
Journal Article
Journal Article
Oncotarget, ISSN 1949-2553, 2015, Volume 6, Issue 18, pp. 15857 - 15870
Journal Article
Journal Article
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 2/2016, Volume 113, Issue 8, pp. 2258 - 2263
Journal Article